Abstract
Chronic rhinosinusitis (CRS) affects 1–4% of the adult population. The etiology of this multifactorial, chronic disease, which leads to a significant impairment of the quality of life, often accompanied by nasal polyposis, is not fully understood. In the past decade, it was presumed that the disease, which causes characteristic eosinophilic infiltration of the nasal mucosa, is triggered by an enhanced (but not classical allergic IgE-type) immune response against fungal organisms in the nasal mucus. If this supposition is correct, then it appears obvious that the administration of amphotericin B nasal spray in adequate concentration following endoscopic polypectomy should be advantageous for these patients, and might even reduce the number of recurrent cases. To check on this assumption, we conducted a prospective randomized placebo-controlled trial involving 33 patients, 30 of whom remained in the study throughout. Patients with nasal polyposis were operated on with an endoscopic technique between 1 November 2005 and 1 October 2006; group A (14 randomly selected patients) were treated with a nasal spray containing 5 mg/ml amphotericin B, while the placebo group B (16 randomly selected patients) received a nasal spray lacking amphotericin B. We evaluated our results with the aid of a modified Lund–Mackay CT score, the SNAQ-11 test (which assesses changes in the symptoms), a quality of life test and endoscopy. The SPSS 14.0 for Windows program was utilized to process the data of examinations performed preoperatively and 1 year postoperatively. The CT scores of the group A patients 1 year after the operation exhibited wide scattering, without signs of recovery. The CT scores of the group B patients indicated a slight improvement, though this did not prove significant relative to group A. Both the SNAQ-11 test and the quality of life test revealed a significant improvement in each group, but the degrees of change in these tests did not differ significantly between the two groups of patients. The endoscopic findings indicated a slight improvement to the advantage of the amphotericin B-treated group 12 months after the operation. These results lead to the conclusion that the administration of amphotericin B nasal spray to patients operated on for nasal polyposis does not give rise to a significant alteration in either CT score, clinical symptoms, or quality of life. The more favorable clinical aspects observed in the amphotericin B-treated group during the endoscopic follow-up did not correspond to an improvement in the symptoms. In connection with the conclusions drawn from this study, the authors discuss the controversial data available on the fungal etiology of CRS. They critically analyze the contradictory observations and conclusions of seven recent clinical studies.
Similar content being viewed by others
References
Lanza DC, Kennedy DW (1997) Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117:S1–S7. doi:10.1016/S0194-5998(97)70001-9
Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28:717–722. doi:10.1093/ije/28.4.717
Fokkens W, Lund V, Mullol J et al (2007) European position paper (EPP) on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1–136
Bent JP, Kuhn FA (1994) Diagnosis of allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 111:580–588. doi:10.1016/S0194-5998(94)70525-9
Hirschberg A, Jókúti A, Darvas Z, Almay K, Répássy G, Falus A (2003) The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta 1. Laryngoscope 113:120–124. doi:10.1097/00005537-200301000-00022
Sanclement JA, Webster P, Thomas J, Ramadan HH (2005) Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115:578–582
Douglas R, Bruhn M, Tan LW, Ooi E, Psaltis A, Wormald PJ (2007) Response of peripheral blood lymphocytes to fungal extracts and staphylococcal superantigen B in chronic rhinosinusitis. Laryngoscope 117:411–414. doi:10.1097/MLG.0b013e31802c0707
Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H (2003) “Eosinophilic fungal rhinosinusitis”: a common disorder in Europe? Laryngoscope 113:264–269. doi:10.1097/00005537-200302000-00013
Katzenstein A, Sale G, Greenberger P (1982) Pathologic findings in allergic aspergillus sinusitis. J Allergy Clin Immunol 72:89–93. doi:10.1016/0091-6749(83)90057-X
DeShazo RD, Swain RE (1995) Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 96:24–35. doi:10.1016/S0091-6749(95)70029-3
Ponikau JU, Sherris DA, Kita H, Kern EB (2002) Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. Allergy Clin Immun 110:862–866. doi:10.1067/mai.2002.130051
Ponikau JU, Sherris DA, Kephart EB, Humburger HA, Frigas E, Gaffey TA et al (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 28:1145–1152
Ponikau JU, Sherris JA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomised, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115:125–131. doi:10.1016/j.jaci.2004.09.037
Pant H, Kette FE, Smiths WB, Macardle PJ, Wormald PJ (2006) Eosinophil mucus chronic rhinosinusitis: clinical subgroups or a homogenous pathogenetic entity? Laryngoscope 116:1241–1247. doi:10.1097/01.mlg.0000224547.14519.ad
Erbek SS, Serefhanoglu K, Erbek S, Demirbilek M, Can F, Tarhan E et al (2008) Clinical subgroups and antifungal susceptibilities in fungal-culture positive patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 265(7):775–780
Corradini C, Del Ninno M, Buonomo A, Nucera E, Paludetti G, Alonzi C et al (2006) (Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 16:188–193
Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgrawf MG, Lund V, Fokkens WJ (2006) Amphotericin B nasal lavages: not a solution for patient with chronic rhinosinusitis. J Allergy Clin Immunol 118:1149–1156. doi:10.1016/j.jaci.2006.07.058
Helbling A, Baumann A, Hänni C, Caversaccio M (2006) Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 120:1023–1025. doi:10.1017/S0022215106002167
Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS (2002) Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 116:261–263
Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Reichelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113:1122–1128. doi:10.1016/j.jaci.2004.03.038
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (2000) Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30:132–140. doi:10.1046/j.1365-2222.2000.00668.x
Lund VJ, Mackay IS (1993) Staging in rhinosinusitis. Rhinology 31:183–184
Fahmy FF, McCombe A, Mckiernan DC (2002) Sino-nasal outcome questionnaire, a patient focussed, rhinosinusitis specific outcome measure. Rhinology 40:195–197
Basu S, Georgalas C, Kumar BN, Desai S (2005) Correlation between symptoms and radiological findings in patients with chronic rhinosinusitis: an evaluation study using the Sinonasal Assessment Questionnaire and Lund–Mackay grading system. Eur Arch Otorhinolaryngol 262:751–754. doi:10.1007/s00405-004-0891-0
Malm L (1997) Assessment and staging of nasal polyposis. Acta Otolaryngol 117:465–467. doi:10.3109/00016489709113422
Shin S, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA et al (2004) Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114:1369–1375. doi:10.1016/j.jaci.2004.08.012
Collins M, Nair S, Smiths W, Kette F, Gillis D, Wormald PJ (2004) Role of local immunoglobulin E production in the pathophysiology of non-invasive fungal sinusitis. Laryngoscope 114:1242–1246. doi:10.1097/00005537-200407000-00019
Gosepath J, Brieger J, Vlachtsis K, Mann WJ (2004) Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 18:9–13
Seung-Heon S, Mi-Kiung Y (2004) Effect of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124:1174–1177. doi:10.1080/00016480410017404
Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H (2006) Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 132:743–747. doi:10.1001/archotol.132.7.743
Heatley DG, McConnell KE, Kille TL, Leverson GE (2001) Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 125:44–48. doi:10.1067/mhn.2001.115909
Wormald PJ, Cain T, Oates L, Hawke L, Wong I (2004) A comparative study of three methods of nasal irrigation. Laryngoscope 114:2224–2227. doi:10.1097/01.mlg.0000149463.95950.c5
Tomooka LT, Murphy C, Davidson TM (2000) Clinical study and literature review of nasal irrigation. Laryngoscope 110:1189–1193. doi:10.1097/00005537-200007000-00023
Wildfeuer A, Seidl HP, Paule I, Haberreiter A (1997) In vitro evaluation of variconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41:309–319
Fittler A, Mayer A, Kocsis B, Gerlinger I, Fónay F, Botz L (2007) Stability testing of amphotericin B nasal spray solutions with chemical and biological analysis. Acta Pharm Hung 77:159–164
Bhattacharyya T, Piccirillo J, Wippold FJ (1997) Relationship between patient based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 123:1189–1192
Kenny TJ, Duncavage J, Bracikowski J, Yildirim A, Murray JJ, Tanner SB (2001) Prospective analysis of sinus symptoms and correlation with paranasal computed tomography scan. Otolaryngol Head Neck Surg 125:40–43. doi:10.1067/mhn.2001.116779
Jornot L, Rochat T, Caruso A, Lacroix J (2005) Effects of amphotericin B on ion transport proteins in airway epithelial cells. J Cell Physiol 204:859–870. doi:10.1002/jcp.20347
Sokol-Anderson ML, Brajtburg J, Medoff G (1986) Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 154:76–83
Kennedy DW, Kuhn FA, Hamilos DI (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind placebo-controlled study. Laryngoscope 115:1793–1799. doi:10.1097/01.mlg.0000175683.81260.26
Rains BM, Mineck CW (2003) Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 17:1–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gerlinger, I., Fittler, A., Fónai, F. et al. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol 266, 847–855 (2009). https://doi.org/10.1007/s00405-008-0836-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-008-0836-0